IndexAlpha is an institutional-grade research and risk-analysis platform built for individual investors. Run the same multi-factor fundamental scoring, Value-at-Risk modelling, and historical-scenario stress testing professional desks rely on — packaged as a research workstation you can open in any browser.
Wide coverage of the US and international markets — NYSE, NASDAQ, AMEX, LSE, ASX, HKEX, SGX, and JPX. Fundamental and risk data refresh daily.
IndexAlpha is an institutional-grade stock research and portfolio risk analysis platform built for individual investors. It surfaces the same fundamental, valuation, dividend-quality, and risk-adjusted analysis professional research desks use — multi-factor scoring with every input visible, Value-at-Risk and Conditional VaR with Monte Carlo and parametric methods, and historical-scenario stress testing against actual price paths from 1987, 2000, 2008, 2020, and 2022. The platform surfaces three workflows: Stock Research, Portfolio Risk Analysis, and the Research Assistant. The SEC's Investor.gov recommends every investor research stocks before buying — IndexAlpha makes that research rigorous and auditable.
Stock Research: Multi-factor scoring across financial health, growth, valuation, and dividend quality. Every dimension is auditable — the underlying metrics, sector comparables, historical valuation bands, and dividend coverage ratios are visible, not hidden behind an opaque rating. Analyst price targets and methodology citations alongside every score. Refreshed daily.
Portfolio Risk Analysis: Value-at-Risk by historical simulation and the Cornish-Fisher method, plus Conditional VaR. Historical-scenario stress testing replays the actual price moves of your holdings (a holding that did not trade then is estimated, and marked so) through the 1987 Black Monday, 2000 dot-com collapse, 2008 Global Financial Crisis, 2020 COVID drawdown, and 2022 rate shock. Output is a specific dollar exposure with recovery time, not a generic percentile.
Research Assistant: Structured analytical output for fundamental comparisons, portfolio-level questions, and methodology lookups. Responses come as typed cards — tables, charts, comparable lists, risk-adjusted peer benchmarks — not freeform paragraphs. Auditable inputs and methodology surfaced alongside every analytical claim.
Watchlists & Portfolios: Track holdings under continuous risk monitoring. Save multiple portfolios to model alternative allocations side by side.
Institutional research terminals are built for professional desks — market-makers, sell-side analysts, and fund managers — with five-figure annual subscriptions per seat. IndexAlpha delivers the analytical depth individual investors actually need — multi-factor stock scoring, portfolio Value-at-Risk, historical-scenario stress testing, risk-adjusted comparables — on a research workstation tuned for individual decision-making rather than market-making, at a fraction of the cost.
Stress tests replay each holding's actual daily prices through past crashes, from our price archive (split-adjusted, dividends not included); a holding that did not trade through a crisis is estimated from the market's fall and your portfolio's beta, and marked "Estimated". Each crisis's market fall and recovery are dated from S&P Dow Jones Indices. Value-at-Risk uses historical simulation and the Cornish-Fisher method, which allows for fat tails; a separate Monte Carlo projection (5,000 fat-tailed paths) shows the range of outcomes. Conditional VaR captures expected loss in the worst 5% of outcomes — the tail risk standard VaR understates.
The research tools are free — stock research, portfolio risk analysis and the assistant cost nothing to use, with no allowance to evaluate and no card to enter. The paid plans are for having that work run for you rather than on request. See the plans page for what each one covers.
No. IndexAlpha is a research and analysis platform — every output is auditable analytical work product, not a recommendation. The underlying methodology, inputs, and assumptions are visible. Investment decisions remain yours. For personalised advice, consult a licensed financial adviser. See Investor.gov on assessing risk tolerance.